Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|April 28, 2017
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in JapaneseYuko Tanabe, Chikako Shimizu, Akinobu Hamada, et al.
BMC Cancer|November 23, 2017
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case reportYukinori Ozaki, Junichi Shindoh, Yuji Miura, et al.
Healthcare (Basel, Switzerland)|July 28, 2026
Association Between a Refined Multidisciplinary Team-Based Care Model and Scalp Cooling Efficacy for Chemotherapy-Induced Alopecia Outcomes Among Breast Cancer Patients: A Single-Institution Retrospective Before-After StudyNobuko Tamura, Yukiko Nagaoka, Yukari Sano, et al.
Breast Cancer (Tokyo, Japan)|January 4, 2024
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapyNaruto Taira, Yuichiro Kikawa, Takayuki Iwamoto, et al.
Cancer Science|January 7, 2024
Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists-Secondary publicationAtsushi Goto, Ken Ohashi, Mitsuhiko Noda, et al.
Breast Cancer Research and Treatment|May 20, 2024
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)Toshimi Takano, Norikazu Masuda, Mitsuya Ito, et al.
JAMA Network Open|August 15, 2025
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical TrialYuichiro Kikawa, Yukari Uemura, Tetsuhiko Taira, et al.
Diabetology International|January 24, 2024
Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publicationAtsushi Goto, Ken Ohashi, Mitsuhiko Noda, et al.
Breast Cancer Research and Treatment|July 20, 2026
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)Meiko Nishimura, Takahiro Kogawa, Keiji Sugiyama, et al.
Genome Medicine|June 9, 2018
A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencingMamoru Kato, Hiromi Nakamura, Momoko Nagai, et al.
Pageof 11